Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Implementation Science: You've Come a Long Way, Baby.

Bauman JL.

Pharmacotherapy. 2018 May;38(5):488-489. doi: 10.1002/phar.2109. Epub 2018 Apr 16. No abstract available.

PMID:
29659038
2.

Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.

Adams KF Jr, Butler J, Patterson JH, Gattis Stough W, Bauman JL, van Veldhuisen DJ, Schwartz TA, Sabbah H, Mackowiak JI, Ventura HO, Ghali JK.

Eur J Heart Fail. 2016 Aug;18(8):1072-81. doi: 10.1002/ejhf.584.

3.

Cost-Effectiveness Of A Novel Pharmacist Guided Warfarin Pharmacogenetic Service.

Gor D, Kim K, Chumnumwat S, Galanter WL, You J, Walton SM, Garofalo J, Duarte J, Krishnan JA, Bauman JL, Nutescu EA.

Value Health. 2015 Nov;18(7):A390. doi: 10.1016/j.jval.2015.09.866. Epub 2015 Oct 20. No abstract available.

4.

Use of a simplified nomogram to individualize digoxin dosing versus standard dosing practices in patients with heart failure.

DiDomenico RJ, Bress AP, Na-Thalang K, Tsao YY, Groo VL, Deyo KL, Patel SR, Bishop JR, Bauman JL.

Pharmacotherapy. 2014 Nov;34(11):1121-31. doi: 10.1002/phar.1480. Epub 2014 Aug 28.

5.

A perspective on re-evaluating digoxin's role in the current management of patients with chronic systolic heart failure: targeting serum concentration to reduce hospitalization and improve safety profile.

Adams KF Jr, Ghali JK, Herbert Patterson J, Stough WG, Butler J, Bauman JL, Ventura HO, Sabbah H, Mackowiak JI, van Veldhuisen DJ.

Eur J Heart Fail. 2014 May;16(5):483-93. doi: 10.1002/ejhf.64. Epub 2014 Feb 23. Review.

6.

Preparing clinical pharmacy scientists for careers in clinical/translational research: can we meet the challenge?: ACCP Research Affairs Committee Commentary.

Parker RB, Ellingrod V, DiPiro JT, Bauman JL, Blouin RA, Welage LS.

Pharmacotherapy. 2013 Dec;33(12):e337-46. doi: 10.1002/phar.1348. Epub 2013 Sep 30.

PMID:
24114730
7.

Torsade de pointes due to dronedarone: déjà vu?

Bauman JL.

Pharmacotherapy. 2012 Aug;32(8):764-6. doi: 10.1002/j.1875-9114.2012.01140.x. No abstract available.

PMID:
23307524
8.

Maintaining pharmacy education's research focus as the academy expands.

Bauman JL, Ascione FJ, Brueggemeier RW, Letendre DE, Roberts JC, Speedie MK, Svensson CK.

Am J Pharm Educ. 2012 Oct 12;76(8):144. doi: 10.5688/ajpe768144. No abstract available.

9.

Are we producing innovators and leaders or change resisters and followers?

Svensson CK, Ascione FJ, Bauman JL, Brueggemeier RW, Letendre DE, Roberts JC, Speedie MK.

Am J Pharm Educ. 2012 Sep 10;76(7):124. doi: 10.5688/ajpe767124. No abstract available.

10.

Reconsidering the length of program accreditation.

Svensson CK, Speedie MK, Roberts JC, Letendre DE, Brueggemeier RW, Bauman JL, Ascione FJ.

Am J Pharm Educ. 2011 Feb 10;75(1):6. No abstract available.

11.

Payment for clinical pharmacy services revisited.

Stubbings J, Nutescu E, Durley SF, Bauman JL.

Pharmacotherapy. 2011 Jan;31(1):1-8. doi: 10.1592/phco.31.1.1. No abstract available.

PMID:
21182353
13.

Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.

Mykytsey A, Bauman JL, Razminia M, Zheutlin T, Wang T, Saleem M, Leal S, Kehoe RF.

J Cardiovasc Pharmacol Ther. 2007 Mar;12(1):36-43.

PMID:
17495256
14.

A method of determining the dose of digoxin for heart failure in the modern era.

Bauman JL, DiDomenico RJ, Viana M, Fitch M.

Arch Intern Med. 2006 Dec 11-25;166(22):2539-45. Erratum in: Arch Intern Med. 2007 Mar 12;167(5):496. Dosage error in article text.

PMID:
17159022
15.

Response to cardiovascular toxicity.

Bauman JL.

South Med J. 2006 Jul;99(7):780; author reply 780. No abstract available.

PMID:
16866068
16.

Mechanisms, manifestations, and management of digoxin toxicity in the modern era.

Bauman JL, Didomenico RJ, Galanter WL.

Am J Cardiovasc Drugs. 2006;6(2):77-86. Review.

PMID:
16555861
17.

The COMET trial.

Bristow MR, Adams KF Jr, Bauman JL, Feldman AM, Giles TD, Goldstein S, Mann DL, Talbert RL.

Congest Heart Fail. 2005 Jan-Feb;11(1):39-47. No abstract available.

18.

Tales of two oral anticoagulants from natural product research and their impact on clinical pharmacy.

Bauman JL.

Pharmacotherapy. 2004 Oct;24(10 Pt 2):166S-168S. Review. No abstract available.

PMID:
15624335
19.

Shifting paradigms in oral anticoagulation management.

Nutescu EA, Bauman JL.

J Cardiovasc Pharmacol Ther. 2004 Sep;9(3):149-50. No abstract available.

PMID:
15378134
20.

Pharmacodynamics of beta-blockers in heart failure: lessons from the carvedilol or metoprolol European trial.

Bauman JL, Talbert RL.

J Cardiovasc Pharmacol Ther. 2004 Jun;9(2):117-28. Review.

PMID:
15309248
21.

Hawthorn.

Fong HH, Bauman JL.

J Cardiovasc Nurs. 2002 Jul;16(4):1-8. Review.

PMID:
12597258
22.

Evidence of the economic benefit of clinical pharmacy services: 1996-2000.

Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL; 2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy.

Pharmacotherapy. 2003 Jan;23(1):113-32. Review.

PMID:
12523470
23.

Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death.

Bauman JL, DiDomenico RJ.

J Cardiovasc Pharmacol Ther. 2002 Jul;7(3):195-202. Review.

PMID:
12232568
24.
25.

Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease.

Schoen MD, DiDomenico RJ, Connor SE, Dischler JE, Bauman JL.

Pharmacotherapy. 2001 Dec;21(12):1455-63.

PMID:
11765297
26.

Cardiovascular Effects of Cocaine: Focus on Hypertension.

Brecklin CS, Bauman JL.

J Clin Hypertens (Greenwich). 1999 Nov;1(3):212-217.

PMID:
11416615
27.

Analysis of the use of digoxin immune fab for the treatment of non-life-threatening digoxin toxicity.

DiDomenico RJ, Walton SM, Sanoski CA, Bauman JL.

J Cardiovasc Pharmacol Ther. 2000 Apr;5(2):77-85.

PMID:
11150387
28.

Rationale, development, and clinical outcomes of a multidisciplinary amiodarone clinic.

Sanoski CA, Schoen MD, Gonzalez RC, Avitall B, Bauman JL.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):146S-151S.

PMID:
9855347
29.

Amiodarone: the re-emergence of a unique antiarrhythmic drug. Introduction.

Bauman JL.

Pharmacotherapy. 1998 Nov-Dec;18(6 Pt 2):119S-120S. Review. No abstract available.

PMID:
9855343
30.

Pharmacists and infectious diseases specialists.

Bauman JL, Murphy JE, Bertino JS Jr.

Clin Infect Dis. 1998 Jul;27(1):229-31. No abstract available.

PMID:
9675494
31.

Prolongation of the QT interval related to cisapride-diltiazem interaction.

Thomas AR, Chan LN, Bauman JL, Olopade CO.

Pharmacotherapy. 1998 Mar-Apr;18(2):381-5.

PMID:
9545159
32.

Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.

Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL.

Pharmacotherapy. 1997 Nov-Dec;17(6):1238-45.

PMID:
9399606
33.

Evaluation of two forms of sustained release nifedipine using 24 h ambulatory blood pressure monitoring.

Gandhi AJ, Murphy CM, Zervopoulos PC, Evans RE, Carter BL, Bauman JL.

Am J Hypertens. 1997 Sep;10(9 Pt 1):992-6.

PMID:
9324104
34.

Economic impact of digoxin toxicity.

Gandhi AJ, Vlasses PH, Morton DJ, Bauman JL.

Pharmacoeconomics. 1997 Aug;12(2 Pt 1):175-81.

PMID:
10169669
35.

Postabsorption concentration peaks with brand-name and generic verapamil: a double-blind, crossover study in elderly hypertensive patients.

Saseen JJ, Porter JA, Barnette DJ, Bauman JL, Zajac EJ Jr, Carter BL.

J Clin Pharmacol. 1997 Jun;37(6):526-34.

PMID:
9208360
36.

Class III antiarrhythmic agents: the next wave.

Bauman JL.

Pharmacotherapy. 1997 Mar-Apr;17(2 Pt 2):76S-83S; discussion 89S-91S. Review.

PMID:
9085343
37.

Serum nifedipine concentrations and response of patients with pulmonary hypertension.

Phillips BG, Bauman JL, Schoen MD, Hoon TJ, Schrader BJ, Rich S.

Am J Cardiol. 1996 May 1;77(11):996-9.

PMID:
8644652
38.

Pharmacologic profile of survivors of acute myocardial infarction at United States academic hospitals.

Phillips BG, Yim JM, Brown EJ Jr, Bittar N, Hoon TJ, Celestin C, Vlasses PH, Bauman JL.

Am Heart J. 1996 May;131(5):872-8.

PMID:
8615304
39.
40.

QT interval prolongation and torsades de pointes due to erythromycin lactobionate.

Oberg KC, Bauman JL.

Pharmacotherapy. 1995 Nov-Dec;15(6):687-92.

PMID:
8602374
41.

Angiotensin-converting enzyme inhibitor use in survivors of acute myocardial infarction.

Yim JM, Hoon TJ, Bittar N, Bauman JL, Brown EJ Jr, Celestin C, Phillips BG, Vlasses PH.

Am J Cardiol. 1995 Jun 1;75(16):1184-6. No abstract available.

PMID:
7762512
42.
43.

Effective use of magnesium for acquired torsade de pointes in a 4-month-old infant.

Bell D, Thoele DG, Mander G, Bauman JL.

Pediatr Cardiol. 1995 Mar-Apr;16(2):79-81.

PMID:
7784240
44.

Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 2. Concentration-effect relationships.

Grawe JJ, Hariman RJ, Winecoff AP, Fischer JH, Bauman JL.

Pharmacotherapy. 1994 Nov-Dec;14(6):704-11.

PMID:
7885974
45.

Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 1. Comparison with sodium bicarbonate and quinidine.

Winecoff AP, Hariman RJ, Grawe JJ, Wang Y, Bauman JL.

Pharmacotherapy. 1994 Nov-Dec;14(6):698-703.

PMID:
7885973
46.

Invasive and noninvasive methods to predict the long-term efficacy of amiodarone: a compilation of clinical observations using meta-analysis.

Roberts SA, Viana MA, Nazari J, Bauman JL.

Pacing Clin Electrophysiol. 1994 Oct;17(10):1590-602.

PMID:
7800560
47.

Cocaine-related sudden cardiac death: a hypothesis correlating basic science and clinical observations.

Bauman JL, Grawe JJ, Winecoff AP, Hariman RJ.

J Clin Pharmacol. 1994 Sep;34(9):902-11. Review.

PMID:
7983233
48.

Bioavailability of total and unbound disopyramide: implications for clinical use of the immediate and controlled-release dosage forms.

Piscitelli DA, Fischer JH, Schoen MD, Hoon TJ, Bauman JL.

J Clin Pharmacol. 1994 Aug;34(8):823-8.

PMID:
7962670
49.

"Late" proarrhythmia due to quinidine.

Oberg KC, O'Toole MF, Gallastegui JL, Bauman JL.

Am J Cardiol. 1994 Jul 15;74(2):192-4. No abstract available.

PMID:
8023791
50.

Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter.

Roberts SA, Diaz C, Nolan PE, Salerno DM, Stapczynski JS, Zbrozek AS, Ritz EG, Bauman JL, Vlasses PH.

Am J Cardiol. 1993 Sep 1;72(7):567-73.

PMID:
8362772

Supplemental Content

Loading ...
Support Center